Searching for genes involved in the pathogenesis of primary immunodeficiency diseases: Lessons from mouse knockouts

Journal of Clinical Immunology

Volumn 17, Issue 2, 1997, Pages 109-126

  Kokron, Cristina M ^a   Bonilla, Francisco A ^a   Oettgen, Hans C ^a   Ramesh, Narayanaswamy ^a   Geha, Raif S ^a   Pandolfi, Franco ^b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b CATHOLIC UNIVERSITY   (Italy)

Author keywords

immune system; knockout mice; primary immunodeficiencies

Indexed keywords

B LYMPHOCYTE; DATA BASE; GENE MAPPING; IMMUNE DEFICIENCY; KNOCKOUT GENE; MOUSE; MUTATION; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; CHROMOSOMES, HUMAN; COMMON VARIABLE IMMUNODEFICIENCY; GENETIC MARKERS; HUMANS; IMMUNE SYSTEM; LINKAGE (GENETICS); MICE; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; MUTATION; PHENOTYPE; T-LYMPHOCYTE SUBSETS;

EID: 0030949394     PISSN: 02719142     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1027322314256     Document Type: Review

References (238)

1. Capecchi MR: Altering the genome by homologous recombination. Science 244:1288-1292, 1989
2. Pfeffer K, Mak TW: Lymphocyte ontogeny and activation in gene targeted mutant mice [Review]. Annu Rev Immunol 12:367-411, 1994
3. Fassler R, Martin K, Forsberg E, Litzenburger T, Iglesias A: Knockout mice: How to make them and why. The immunological approach [Review]. Int Arch Allergy Immunol 106:323-334, 1995
4. Brandon EP, Idzerda RL, McKnight GS: Targeting the mouse genome: A compendium of knockouts (parts I, II, and III). Curr Biol 5:625-634, 758-765, 873-881, 1995
5. Mombaerts P, Iacomini J, Johnson RS, Herrup K, Tonegawa S, Papaioannou VE: RAG-1-deficient mice have no mature B and T lymphocytes. Cell 68:869-877, 1992
6. Shinkai Y, Rathbun G, Lam KP, Oltz EM, Stewart V, Mendelsohn M, Charron J, Datta M, Young F, Stall AM, Alt FW: Rag-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell 68:855-867, 1992
7. Chen J, Lansford R, Stewart V, Young F, Alt FW: RAG-2-deficient blastocyst complementation: An assay of gene function in lymphocyte development. Proc Natl Acad Sci USA 90:4528-4532, 1993
8. Field SJ, Johnson RS, Mortensen RM, Papaioannou VE, Spiegelman BM, Greenberg ME: Growth and differentiation of embryonic stem cells that lack an intact c-fos gene. Proc Natl Acad Sci USA 89:9306-9310, 1992
9. Mortensen RM, Conner DA, Chao S, Geisterfer LA, Siedman JG: Production of homozygous mutant ES cells with a single targeting construct. Mol Cell Biol 12:2391-2395, 1992
10. Gu H, Zou YR, Rajewsky K: Independent control of immunoglobulin switch recombination at individual switch regions evidenced through Cre-loxP-mediated gene targeting. Cell 73:1155-1164, 1993
11. Primary immunodeficiency diseases. Report of a WHO scientific group. Clin Exp Immunol 99:1-24, 1995
12. Anderson DC, Springer TA: Leukocyte Adhesion Deficiency: An inherited defect in the Mac-1, LFA-1 and p 150, 95 glycoproteins. Annu Rev Med 38:175-194, 1987
13. Fischer A, Lisokowa-Cropierre B, Anderson DC, Springer RA: Leukocyte adhesion deficiency: Molecular basis and functional consequences. Immunodefic Rev 1:39-54, 1988
14. Kishimoto TK, Hollander N, Roberts TM, Anderson DC, Springer TA: Heterogeneous mutations in the β subunit common to the LFA-1, Mac-1, and p150,95 glycoproteins cause leukocyte adhesion deficiency. Cell 50:193-202, 1987
15. Schwarz K, Gauss GH, Ludwig L, Pannicke U, Li Z, Lindner D, Friedrich W, Seger RA, Hansen-Hagge TE, Desiderio S, Lieber MR, Bartram CL: RAG mutations in human B cell-negative SCID. Science 274:97-99, 1996
16. Hitzig WH. The swiss type of agammaglobulinemia. In Immunologic Deficiency Disease in Man, D Bergsma, R Good. New York, The National Foundation - March of Dimes, 1968, p 90
17. Zhou H, Glimcher LH: Human MHC Class II gene transcription directed by the carobxyl terminus of CIITA, one of the defective genes in the type II MHC combined immune deficiency. Immunity 2:545-553, 1995
18. Klein C, Lisowska-Grospierre B, LeDeist F, Fischer A, Griscelli C: Major histocompatibility complex class II deficiency: Clinical manifestations, Immunologic features, and outcome. J Pediatr 123:921-928, 1993
19. Mach B, Steimle V, Reith W: MHC class II deficient combined immunodeficiency: A disease of gene regulation. Immunol Rev 138:207-221, 1994
20. Cohen PL, Eisenberg RA: Lpr and gld: Single gene models of systemic autoimmunity and lymphoproliferative disease. Annu Rev Immunol 9:243-269, 1991
21. Fisher GH, Rosenberg FJ, Straus SE, Dale JK, Middleton LA, Lin AY, Strober W, Lenardo MJ, Puck JM: Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoprolipherative syndrome. Cell 81:935-946, 1995
22. Kelly A, Powis SH, Kerr L-A, Mockridge I, Elliot T, Bastin J, Uchanska-Ziegler B, Ziegler A, Trowsdale J, Townsed A: Assembly and function of the two ABC transporter proteins encoded in the human major histocompatibility complex. Nature 355:641-644, 1992
23. de la Salle H, Hanau D, Fricker D, Urlacher A, Kelly A, Salamero J, Powis SH, Donato L, Bausinger H, Laforet M, Jeras M, Spehner D, Bieber T, Falkenrodt A, Cazenave J-P, Trowsdale J, Tonigo M-M: Homozygous human TAP peptide transporter mutation in HLA class I deficiency. Science 265:237-240, 1994
24. Marcadet A, Cohen D, Dausset J, Fischer A, Durandy A, Griscelli C: Genotyping with DNA probes in combined immunodeficiency syndrome with defective expression of HLA. N Engl J Med 312:1287-1292, 1985
25. Van Kaer L, Ashton-Rickardt PG, Ploegh HL, Tonegawa S: Tap1 mutant mice are deficient in antigen presentation, surface class I molecules, and CD4-8+ T cells. Cell 71:1205-1214, 1992
26. Scher I: The CBA/N mouse strain: an experimental model illustrating the influence of the X-chromosome on immunity. Adv Immunol 33:1-71, 1982
27. Amsbaugh DF, Hansen CT, Prescot B, Stashak PW, Barthold DR, Baker PJ: Genetic control of the antibody response to type III pneumococcal polysacharides in mice. I. Evidence that an X-linked gene plays a decisive role in determining responsiveness. J Exp Med 136:931-936, 1972
28. Kahn WN, Alt FW, Gerstein RM, Malynn BA, Larsson I, Rathbun G, Davidson L, Muller S, Kantor AB, Herzenberg LA, Rosen FS, Sideras P: Defective B cell development and function in btk-deficient mice. Immunity 3:283-299, 1995
29. Kerner JD, Appleby MW, Mohr RN, Chien S, Rawlings DJ, Maliszewski CR, Witte ON, Perlmutter RM: Impaired expansion of mouse B cell progenitors lacking Btk. Immunity 3:301-312, 1995
30. Bruton OC: Agammaglobulinemia. Pediatrics 9:722-728, 1952
31. Rosen FS, Cooper MD, Wedgwood RJP: The primary immunodeficiencies. N Engl J Med 311:235-242, 300-310, 1984
32. Saffran DC, Parolini O, Fitch-hilgenberg ME, Rawlings DJ, Afar DEH, Witte ON, Conley ME: A point mutation in the SH2 domain of Brutton's tyrosine kinase in atypical X-linked agammaglobulinemia. N Engl J Med 330:1488-1491, 1994
33. Wortis HH, Burkly L, Hughes D, Roschelle S, Waneck G: Lack of mature B cells in nude mice with X-linked immune deficiency. J Exp Med 155:903-913, 1982
34. Karagogeos D, Rosenberg N, Wortis HH: Early arrest in B cell development in nude, X-linked immune deficient mice. Eur J Immunol 16:1125-1130, 1986
35. Rosen FS, Kevy SV, Merler E, Janeway CA, Gitlin D: Recurrent bacterial infections and dysgammaglobulinemia: Deficiency of 7S gammaglobulins in the presence of elevated 19S gammaglobulins. Pediatrics 28:182-195, 1961
36. Notarangelo LD, Duse M, Ugazio AG: Immunodeficiency with hyper-IgM (HIM). Immunodef Rev 3:101-122, 1992
37. Fuleihan R, Ramesh N, Loh R, Jabara H, Rosen FS, Chatila T, Fu SM, Stamenkovic I, Geha RS: Defective expression of the CD40 ligand in X chromosome-linked immunoglobulin deficiency with normal or elevated IgM. Proc Natl Acad Sci USA 90:2170-2173, 1993
38. Allen RC, Armitage RJ, Conley ME, Rosenblatt H, Jenkins NA, Copeland NG, Bedell MA, Edelhoff S, Disteche CM, Simoneaux DK, Fanslow WC, Belmont J, Spriggs MK: CD40 ligand gene defects responsible for X-linked hyper IgM syndrome. Science 259:990-993, 1993
39. Aruffo A, Farrington M, Hollenbaugh D, Li X, Milatovich A, Nonoyama S, Bajorath J, Grosmaire L, Stenkamp R, Neubauer M, Roberts RL, Noelle RJ, Ledbetter JA, Francke U, Ochs HD: The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome. Cell 72:291-300, 1993
40. DiSanto JP, Bonnefoy JY, Gauchat JF, Fischer A, De Saint Basile G: CD40 ligand mutations in X-linked immunodeficiency with hyper-IgM. Nature 361:341-543, 1993
41. Pelleitier M, Montplaisir S: The nude mouse: A model of deficient T-cell function. Meth Arch Exp Pathol 7:149-166, 1975
42. Conley ME, Buckley RH, Hong R, Guerra-Hanson C, Roifman CM, Brochstein JA, Pahwa S, Puck JM: X-linked severe combined immunodeficiency: Diagnosis in males with sporadic severe combined immunodeficiency and clarification of clinical findings. J Clin Invest 85:1548-1554, 1990
43. Noguchi M, Yi H, Rosenblatt HM, Filipovich AH, Adelstein S, Modi WS, McBride OW, Leonard WJ: Interleukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans. Cell 73:147-157, 1993
44. Voss SD, Hong R, Sondel PM: Severe combined immunoiteficiency, interleukin-2 (IL-2) and the IL-2 receptor: Experiments of nature continue to point the way. Blood 83:626-635, 1994
45. DiSanto JP, Muller W, Guy GD, Fischer A, Rajewsky K: Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor gamma chain. Proc Natl Acad Sci USA 92:377-381, 1995
46. Russell SM, Tayebi N, Nakajima H, Riedy MC, Roberts JL, Aman MJ, Migone T-S, Noguchi M, Markert MI, Buckley RH, O'Shea JJ, Leonard WJ: Mutation of Jak3 in a patient with SCID: essential role of Jak3 in lymphoid development. Science 270: 797-800, 1995
47. Macchi P, Villa A, Giliani S, Sacco MG, Frattini A, Porta F, Ugazio AG, Johnston JA, Candotti F, O'Shea JJ, Vezzoni P, Notarangelo LD: Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID). Nature 377:65-68, 1995
48. Nosaka T, van DJ, Tripp RA, Thierfelder WE, Witthuhn BA, McMickle AP, Doherty PC, Grosveld GC, Ihle JN: Defective lymphoid development in mice lacking Jak3. Science 270:800-802, 1995
49. Arpaia E, Shahar M, Dadi H, Cohen A, Roifman CM: Defective T cell receptor signaling and CD8+ thymic selection in humans lacking Zap-70 kinase. Cell 76:947-958, 1994
50. Elder ME, Lin D, Clever J, Chan AC, Hope TJ, Weiss A, Parslow TG: Human severe combined immunodeficiency due to a defect in Zap-70, T cell tyrosine kinase. Science 264:1596-1599, 1994
51. Chan AC, Kadlecek T, Elder ME, Filipovich AH, Kuo W-L, Iwashima M, Parslow TG, Weiss A: ZAP-70 deficiency in an autosomal recessive form of severe combined immunodeficiency. Science 264:1599-1601, 1994
52. Negishi I, Motoyama N, Nakayama K, Nakayama K, Senju S, Hatakeyama S, Zhang Q, Chan AC, Loh DY: Essential role for ZAP-70 in both positive and negative selection of thymocytes. Nature 376:435-438, 1995
53. Migchielsen AA, Breuer ML, van RM, te RH, Zurcher C, Ossendorp F, Toutain S, Hershfield MS, Berns A, Valerio D: Adenosine-deaminase-deficient mice die perinatally and exhibit liver-cell degeneration, atelectasis and small intestinal cell death. Nat Genet 10:279-287, 1995
54. Hirchhorn R: Adenosine deaminase deficiency. Immunodef Rev 2:175-198, 1990
55. Schwartzberg PL, Stall AM, Hardin JD, Bowdish KS, Humaran T, Boast S, Harbison ML, Robertson EJ, Goff SP: Mice homozygous for the ablm1 mutation show poor viability and depletion of selected B and T cell populations. Cell 65:1165-1175, 1991
56. Tybulewicz VLJ, Crawford CE, Jackson PK, Bronson RT, Mulligan RC: Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene. Cell 65: 1153-1163, 1991
57. Barlow C, Hirotsune S, Paylor R, Liyanage M, Eckhaus M, Collins F, Shiloh Y, Crawley JN, Ried T, Tagle D, Wymshaw-Boris A: Atm-deficient mice: a paradigm of ataxia telangiectasia. Cell 86:159-171, 1996
58. Freeman GJ, Borriello F, Hodes RJ, Reiser H, Hathcock KS, Laszlo G, McKnight AJ, Kim J, Du L, Lombard DB, Gray GS, Nadler LM, Sharpe AH: Uncovering of functional alternative CTLA-4 counter-receptor in B7-deficient mice [see comments]. Science 262:907-909, 1993
59. Knudson CM, Tung KS, Tourtellotte WG, Brown GA, Korsmeyer SJ: Bax-deficient mice with lymphoid hyperplasia and male germ cell death. Science 270:96-99, 1995
60. Nakayama K, Nakayama K, Negishi I, Kuida K, Sawa H, Loh DY: Targeted disruption of Bcl-2 alpha beta in mice: Occurrence of gray hair, polycystic kidney disease, and lymphocytopenia. Proc Natl Acad Sci USA 91:3700-3704, 1994
61. Nakayama K, Nakayama K, Dustin LB, Loh DY: T-B cell interaction inhibits spontaneous apoptosis of mature lymphocytes in Bcl-2-deficient mice. J Exp Med 182:1101-1109, 1995
62. Nakayama K, Nakayama K, Negishi I, Kuida K, Shinkai Y, Louis MC, Fields LE, Lucas PJ, Stewart V, Alt FW, Loh DY: Disappearance of the lymphoid system in Bcl-2 homozygous mutant chimeric mice. Science 261:1584-1588, 1993
63. Veis DJ, Sorenson CM, Shutter JR, Korsmeyer SJ: Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell 75:229-240, 1993
64. Kamada S, Shimono A, Shinto Y, Tsujimura T, Takahashi T, Noda T, Kitamura Y, Kondoh H, Tsujimoto Y: bcl-2 deficiency in mice leads to pleiotropic abnormalities: Accelerated lymphoid cell death in thymus and spleen, polycystic kidney, hair hypopigmentation, and distorted small intestine. Cancer Res 55:354-359, 1995
65. Zijlstra M, Bix M, Simister NE, Loring JM, Raulet DH, Jaenisch R: Beta-2 microglobulin deficient mice lack CD4-8+ cytolytic T cells. Nature 344:742-746, 1990
66. Koller BH, Marrack P, Kappler JW, Smithies O: Normal development of mice deficient in β2M, MHC class I proteins and CD8+ T cells. Science 248:1227-1230, 1990
67. Wagner N, Lohler J, Kunkel EJ, Ley K, Leung E, Krissansen G, Rajewsky K, Muller W: Critical role for b7 integrins in formation of the gut-associated lymphoid tissue. Nature 382:366-370, 1996
68. Wang Z-Q, Ovitt C, Grigoriadis AE, Mohle-Steinlein U, Ruther U, Wagner EF: Bone and haemotopoietic defects in mice lacking c-fos. Nature 360:741-745, 1992
69. Johnson RS, Spiegelman BM, Papaioannou V: Pleiotropic effects of a null mutation in the c-fos proto-oncogene. Cell 71:577-586, 1992
70. Mucenski ML, McLain K, Kier AB, Swerdlow SH, Schreiner CM, Miller TA, Pietryga DW, Scott WJ Jr, Potter S: A functional c-myb gen is required for normal murine fetal hepatic hematopoiesis. Cell 65:677-689, 1991
71. Screpanti I, Romani L, Musiani P, Modesti A, Fattori E, Lazzaro D, Sellitto C, Scarpa S, Bellavia D, Lattanzio G, Bistoni F, Frati L, Cortese R, Gulino A, Ciliberto G, Constantini F, Poli V: Lymphoproliferative disorder and imbalanced T-helper response in C/EBP beta-deficient mice. EMBO J 14:1932-1941, 1995 (published Erratum appears in EMBO J, 14:3596, 1995)
72. Fischer MB, Ma M, Goerg S, Zhou X, Xia J, Finco O, Han S, Kelsoe G, Howard RG, Rothstein TL, Kremmer E, Rosen FS, Carroll MC: Regulation of the B cell response to T-dependent antigens by classical pathway complement. J Immunol 157:549-556, 1996
73. Wessels MR, Butko P, Ma M, Warren HB, Lage AL, Carroll MC: Studies of group B streptococcal infection in mice deficient in complement component C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity. Proc Natl Acad Sci USA 92:11490-11494, 1995
74. Hopken UE, Lu B, Gerard NP, Gerard C: The C5a chemoattractant receptor mediates mucosal defense to infection. Nature 383:86-89, 1996
75. Killeen N, Stuart SG, Littman DR: Development and function of T cells in mice with a disrupted CD2 gene. EMBO J 11:4329-4336, 1992
76. Malissen M, Gillet A, Ardouin L, Bouvier G, Trucy J, Ferrier P, Vivier E, Malissen B: Altered T cell development in mice with a targeted mutation of the CD3-epsilon gene. EMBO J 14:4641-4653, 1995
77. Malissen M, Gillet A, Rocha B, Trucy J, Vivier E, Boyer C, Kontgen F, Brun N, Mazza G, Spanopoulou E, et al.: T cell development in mice lacking the CD3-zeta/eta gene. EMBO J 12:4347-4355, 1993
78. Ohno H, Goto S, Taki S, Shirasawa T, Nakano H, Miyatake S, Aoe T, Ishida Y, Maeda H, Shirai T, Rajewsky K, Saito T: Targeted disruption of the CD3 eta locus causes high lethality in mice: Modulation of Oct-1 transcription on the opposite strand. EMBO J 13:1157-1165, 1994
79. Koyasu S, Hussey RE, Clayton LK, Lerner A, Pedersen R, Delany HP, Chau F, Reinherz EL: Targeted disruption within the CD3 zeta/eta/phi/Oct-1 locus in mouse. EMBO J 13:784-797, 1994
80. Love PE, Shores EW, Johnson MD, Tremblay ML, Lee EJ, Grinberg A, Huang SP, Singer A, Westphal H: T cell development in mice that lack the zeta chain of the T cell antigen receptor complex. Science 261:918-921, 1993
81. Shores EW, Huang K, Tran T, Lee E, Grinberg A, Love PE: Role of TCR zela chain in T cell development and selection. Science 266:1047-1050, 1994
82. + cells but markedly decreased helper cell activity in mice lacking CD4. Nature 353:180-184, 1991
83. Rahemtulla A, Kundig TM, Narendran A, Bachmann MF, Julius M, Paige CJ, Ohashi PS, Zinkernagel RM, Mak TW: Class II major histocompatibility complex-restricted T cell function in CD4-deficient mice. Eur J Immunol 24:2213-2218, 1994
84. Tarakhovsky A, Muller W, Rajewsky K: Lymphocyte populations and immune responses in CD5-deficient mice. Eur J Immunol 24:1678-1684, 1994
85. Fung-Leung W, Schilham MW, Rahemtulla A, Kundig TM, Vollenweider M, Potter J, van Ewijk W, Mak TW: CD8 is needed for development of cytotoxic T cells but not helper T cells. Cell 65:443-449, 1991
86. Fung-Leung W, Kundig TM, Ngo K, Panakos J, De Sousa-Hitzler J, Wang E, Ohashi PS, Mak TW, Lau CY: Reduced thymic maturation but normal effector function of CD8+ T cells in CD8 beta gene-targeted mice. J Exp Med 180:959-967, 1994
87. Crooks ME, Littman DR: Disruption of T lymphocyte positive and negative selection in mice lacking the CD8 beta chain. Immunity 1:277-285, 1994
88. Haziot A, Ferraro E, Kontgen F, Hijiya N, Yamamoto S, Silver J, Stewart CL, Goyert SM: Resistance to endotoxin shock and reduced dissemination of Gram-Negative bacteria in CD14-deficient mice. Immunity 4:407-414, 1996
89. Wilson RW, Ballantyne CM, Smith CW, Montgomery C, Bradley A, O'brien WE, Beaudet AL: Gene targeting yields a CD18-mutant mouse for study of inflammation. J Immunol 151:1571-1578, 1993
90. Rickert RC, Rajewsky K, Roes J: Impairement of T-cell-dependent B-cell responses and B-1 cell development in CD19-deficient mice. Nature 376:352-355, 1995
91. Engel P, Zhou L-J, Ord DC, Sato S, Koller B, Tedder TF: Abnormal B lymphocyte development, activation and differentiation in mice that lack or overexpress the CD19 signal transduction molecule. Immunity 3:39-50, 1995
92. Yu P, Kosco VM, Richards M, Kohler G, Lamers MC: Negative feedback regulation of IgE synthesis by murine CD23. Nature 369:753-756, 1994
93. Shahinian A, Pfeffer K, Lee KP, Kundig TM, Kishihara K, Wakeham A, Kawai K, Ohashi PS, Thompson CB, Mak TW: Differential T cell costimulatory requirements in CD28-deficient mice. Science 261:609-612, 1993
94. Lucas PJ, Negishi I, Nakayama K, Fields LE, Loh DY: Naive Cd28-deficient T cells can initiate but not sustain an in vitro antigen-specific immune response. J Immunol 154:5757-5768, 1995
95. Amakawa R, Hakem A, Kundig TM, Matsuyama T, Simard JJ, Timms E, Wakeham A, Mittruecker HW, Griesser H, Takimoto H, Schmits R, Shahinian A, Ohashi P, Penninger JM, Mak TW: Impaired negative selection of T cells in Hodgkin's disease antigen CD30-deficient mice. Cell 84:551-562, 1996
96. Kawabe T, Naka T, Yoshida K, Tanaka T, Fujiwara H, Suematsu S, Yoshida N, Kishimoto T, Kitutani H: The immune responses in CD40-deficient mice: Impaired immunobglobulin class switching and germinal center formation. Immunity 1:167-178, 1994
97. Castigli E, Alt FW, Davidson L, Bottaro A, Mizoguchi E, Bhan AK, Geha RS: CD40-deficient mice generated by recombination-activating gene-2-deficient blastocyst complementation. Proc Natl Acad Sci USA 91:12135-12139, 1994
98. Kamanaka M, Yo P, Yasui T, Yoshida K, Kawabe T, Horii T, Kishimoto T, Kitutani H: Protective role of CD40 in Leishmania major infection at two distinct phases of cell-mediated immunity. Immunity 4:275-281, 1996
99. Xu J, Foy TM, Laman JD, Elliott EA, Dunn JJ, Waldschmidt TJ, Elsemore J, Noelle RJ, Flavell RA: Mice deficient for the CD40 ligand. Immunity 1:423-431, 1994 (published Erratum appears in Immunity 1:613, 1994)
100. Grewal IS, Xu J, Flavell RA: Impairment of antigen-specific T-cell priming in mice lacking CD40 ligand. Nature 378:617-620, 1995
101. Soong L, Xu J-C, Grewal IS, Kima P, Sun J, Longley BJ Jr, Ruddle NH, McMahon-Pratt D, Flavell RA: Disruption of CD40-CD40 ligand interactions results in an enhanced susceptibility to Leishmania amazonensis infection. Immunity 4:263-273, 1996
102. Manjunath N, Correa M, Ardman M, Ardman B: Negative regulation of T-cell adhesion and activation by CD43. Nature 377:535-538, 1995
103. Kishihara K, Penninger J, Wallace VA, Kundig TM, Kawai K, Wakeham A, Timms E, Pfeffer K, Ohashi PS, Thomas ML, Furlonger Ce, Paige CJ, Mak TW: Normal B lymphocyte development but impaired T cell maturation in CD45-exon 6 protein tyrosine phosphatase-deficient mice. Cell 74:143-156, 1993
104. Kong YY, Kishihara K, Sumichika H, Nakamura T, Kaneko M, Nomoto K: Differential requirements of CD45 for lymphocyte development and function. Eur J Immunol 25:3431-3436, 1995
105. Byth KF, Conroy L, Howlett S, Smith A, May J, Alexander D, Holmes N: CD45-null transgenic mice reveal a positive regulatory role for CD45 in early thymocyte development, in the selection of CD4+CD8+ thymocytes, and in B cell maturation. J Exp Med 183:1707-1718, 1996
106. Chang C-H, Guerder S, Hong S-C, Van Ewijk W, Flavell RA: Mice lacking the MHC class II transactivator (CIITA) show tissue-specific impairment of MHC class II expression. Immunity 4:167-178, 1996
107. Ahearn JM, Fischer MB, Croix D, Goerg S, Ma M, Xia J, Zhou X, Howard RG, Rothstein TL, Carroll MC: Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen. Immunity 4:251-262, 1996
108. Waterhouse P, Penninger JM, Timms E, Wakeham A, Shahinian A, Lee KP, Thompson CB, Griesser H, Mak TW: Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science 270:985-988, 1995
109. Tivol EA, Borriello F, Schweitzer AN, Lynch WP, Bluestone JA, Sharpe AH: Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 3:541-547, 1995
110. Kirchgessner CU, Patil CK, Evans JW, Cuomo CA, Fried LM, Carter T, Oettinger MA, Brown JM: DNA-dependent kinase (p350) as a candidate gene for the murine SCID defect. Science 267:1178-1183, 1995
111. Gu H, Marth JD, Orban PC, Mossmann H, Rajewsky K: Deletion of a DNA polymerase beta gene segment in T cells using cell type-specific gene targeting [see comments]. Science 265:103-106, 1994
112. Labow MA, Norton CR, Rumberger JM, Lombard-Gillooly KM, Shuster DJ, Hubbard J, Bertko R, Knaack PA, Terry RW, Harbison ML, Kontgen F, Stewart CL, McIntyre KW, Will PC, Burns DK, Wolitzky BA: Characterization of E-selectin-deficient mice: Demonstration of overlapping function of the endothelial selectins. Immunity 1:709-720, 1994
113. Zhuang Y, Soriano P, Weintraub H: The helix-loop-helix gene E2A is required for B cell formation. Cell 79:875-884, 1994
114. Bain G, Maandag EC, Izon DJ, Amsen D, Kruisbeek AM, Weintraub BC, Krop I, Schlissel MS, Feeney AJ, van der Valk RM, te Riele HPJ, Berns A, Murre C: E2A proteins are required for proper B cell development and initiation of immunoglobulin gene rearrangements [see comments]. Cell 79:885-892, 1994
115. Yamasaki L, Jacks T, Bronson R, Goillot E, Harlow E, Dyson NJ: Tumor induction and tissue atrophy in mice lacking E2F-1 Cell 85:537-548, 1996
116. Field ST, Tsai F-Y, Kuo F, Zubiaga AM, Kaelin WGJ, Livingston DM, Orkin SH, Greenberg ME: E2F-1 functions in mice to promote apoptosis and suppress proliferation. Cell 85:549-561, 1996
117. Lin H, Grosschedl R: Failure of B-cell differentiation in mice lacking the transcription factor EBF. Nature 376:263-267, 1995
118. Borles JC, Willerford DM, Grevein D, Davidson L, Camus A, Martin P, Stehelin D, Alt FW: Increased T-cell apoptosis and B-cell differentiation induced by inactivation of the ETS-1 proto-oncogene. Nature 377:635-638, 1995
119. Muthusamy N, Barton K, Leiden JM: Defective activation and survival of T cells lacking the ETS-1 transcription factor. Nature 377:639-642, 1995
120. Schilham MW, Oosterwegel MA, Moerer P, Ya J, Boer PAJ, Wetering M, Verbeek S, Lamers W, Kruisbeek AM, Cumano A, Clevers H: Defects in cardiac outflow tract formation and pro-B-lymphocyte expansion in mice lacking Sox-4. Nature 380:711-714, 1996
121. Jacobson BA, Panka DJ, Nguyen KA, Erikson J, Abbas AK, Marshak RA: Anatomy of autoantibody producton: Dominant localization of antibody-producing cells to T cell zones in Fas-deficient mice. Immunity 3:509-519, 1995
122. Takai T, Ono M, Hikida M, Ohmori H, Ravetch JV: Augmented humoral and anaphylactic responses in FcγRII-deficient mice. Nature 379:346-349, 1996
123. Hazenbos WLW, Gessner JE, Hofhuis FMA, Kuipers H, Meyer D, Heijnen IAFM, Schmidt RE, Sandor M, Capel PJA, Daeron M, van de Winkel JGJ, Verbeek JS: Impaired IgG-dependent anaphylaxis and Arthus reaction in FcγRIII (CD16) deficient mice. Immunity 5:181-188, 1996
124. Takai T, Li M, Sylvestre D, Clynes R, Ravetch JV: FcR gamma chain deletion results in pleiotrophic effector cell defects. Cell 76:519-529, 1994
125. Mackarehtschian K, Hardin JD, Moore KA, Boast S, Goff SP, Lemischka IR: Targeted disruption of the flk2/flt3 gene leads to deficiencies in primitive hematopoietic progenitors. Immunity 3:147-161, 1995
126. Tsai F, Keller G, Kuo F, Weiss M, Chen J, Rosenblatt M, Alt F, Orkin S: An early haematopoietic defect in mice lacking the transcription factor GATA-2. Nature 371:221-226, 1994
127. Stanley E, Lieschke GJ, Grail D, Metcalf D, Hodgson G, Gall JA, Maher DW, Cebon J, Sinickas V, Dunn AR: Granulocyte/ macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology. Proc Natl Acad Sci USA 91:5592-5596, 1994
128. Ebnet K, Hausmann M, Lehmann-Grube F, Mullbacher A, Kopf M, Lamers M, Simon MM: Granzyme A-deficient mice retain potent cell-mediated cytotoxicity. EMBO J 14:4230-4239, 1995
129. Sligh JJ, Ballantyne CM, Rich SS, Hawkins HK, Smith CW, Bradley A, Beaudet AL: Inflammatory and immune responses are impaired in mice deficient in intercellular adhesion molecule I. Proc Natl Acad Sci USA 90:8529-8533, 1993
130. Dalton DK, Pitts MS, Keshav S, Figari IS, Bradley A, Stewart TA: Muliple defects of immune cell function in mice with disrupted interferon-gamma genes [see comments]. Science 259: 1739-1742, 1993
131. Huang S, Hendriks W, Althage A, Hemmi S, Bluethmann H, Kamijo R, Vilcek J, Zinkernagel RM, Aguet M: Immune response in mice that lack the interferon-gamma receptor [see comments]. Science 259:1742-1745, 1993
132. Matthys P, Froyen G, Verdot L, Huang S, Sobis H, Van Damme J, Vray B, Aguet M, Billiau A: IFN-γ receptor-deficient mice are hypersensitive to the anti-CD3-induced cytokine release syndrome and thymocyte apoptosis. J Immunol 155:3823-3829, 1995
133. Roes J, Rajewsky K: Immunoglobulin D (IgD)-deficient mice reveal an auxiliary receptor function for IgD in antigen-mediated recruitment of B cells. J Exp Med 177:45-55, 1993
134. Nischke L, Kosco MH, Kohler G, Lamers MC: Immunoglobulin D-deficient mice can mount normal immune responses to thymus-independent and -dependent antigens. Proc Natl Acad Sci USA 90:1887-1891, 1993
135. Oettgen HC, Martin TR, Wynshaw BA, Deng C, Drazen JM, Leder P: Active anaphylaxis in Ige-deficient mice. Nature 370: 367-370, 1994
136. Georgopoulos K, Bigby M, Wang JH, Molnar A, Wu P, Winandy S, Sharpe A: The Ikaros gene is required for the development of all lymphoid lineages. Cell 79:143-156, 1994
137. Winandy S, Wu P, Georgeopoulos K: A dominant mutation in the Ikaros gene leads to rapid development of leukemia and lymphoma. Cell 83:289-299, 1995
138. Zheng H, Fletcher D, Kozak W, Jiang M, Hofmann KJ, Conn CA, Soszynski D, Grabiec C, Trumbauer ME, Shaw A, Kostura MJ, Stevens K, Rosen H, North RJ, Chen HY, Tocci MJ, Kluger MJ, van der Ploeg LHT: Resistance to fever induction and impaired acute-phase response in interleukin-1 beta-deficient mice. Immunity 3:9-19, 1995
139. Schorle H, Holtschke T, Hunig T, Schimpl A, Horak I: Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting. Nature 352:621-624, 1991
140. Kundig TM, Schorle H, Bachmann MF, Hengartner H, Zinkernagel RM, Horak I: Immune responses in interleukin-2-deficient mice. Science 262:1059-1061, 1993
141. Sadlack B, Merz H, Schorle H, Schimpl A, Feller AC, Horak I: Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene [see comments]. Cell 75:253-261, 1993
142. Kramer S, Schimpl A, Hunig T: Immunopathology of interleukin (IL) 2-deficient mice: thymus dependence and suppression by thymus-dependent cells with an intact IL-2 gene. J Exp Med 182:1769-1776, 1995
143. Willerford DM, Chen J, Ferry JA, Davidson L, Ma A, Alt FW: Interleukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment. Immunity 3:521-530, 1995
144. Suzuki H, Kundig TM, Furlonger C, Wakeham A, Timms E, Matsuyama T, Schmits R, Simard JJ, Ohashi PS, Griesser H, Tanigushi T, Paige CJ, Mak TW: Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor beta. Science 268:1472-1476, 1995
145. Cao X, Shores EW, Hu LJ, Anver MR, Kelsall BL, Russell SM, Drago J, Noguchi M, Grinberg A, Bloom ET, Paul WE, Katz SI, Love PE, Leonard WJ: Defective lymphoid development in mice lacking expression of the common cytokine receptor gamma chain. Immunity 2:223-238, 1995
146. Nishinakamura R, Nakayama N, Hirabayashi Y, Inoue T, Aud D, McNeil T, Azuma S, Yoshida S, Toyoda Y, Arai K, Miyajima A, Murray R: Mice deficient for the IL-3/GM-CSF/IL-5 beta c receptor exhibit lung pathology and impaired immune response, while beta IL3 receptor-deficient mice are normal. Immunity 2:211-222, 1995
147. Kuhn R, Rajewsky K, Muller W: Generation and analysis of interleukin-4 deficient mice. Science 254:707-710, 1991
148. Kopf M, Le GG, Bachmann M, Lamers MC, Bluethmann H, Kohler G: Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature 362:245-248, 1993
149. Vajdy M, Kosco VM, Kopf M, Kohler G, Lycke N: Impaired mucosal immune responses in interleukin 4-targeted mice. J Exp Med 181:41-53, 1995
150. Kopf M, Brombacher F, Hodgkin PD, Ramsay AJ, Milbourne EA, Dai WJ, Ovington KS, Behm CA, Kohler G, Young IG, Matthaei KI: IL-5-deficient mice have a developmental defect in CD5+ B-1 cells and lack eosinophilia but have normal antibody and cytotoxic T cell responses. Immunity 4:15-24, 1996
151. Foster PS, Hogan SP, Ramsay AJ, Matthaei KI, Young IG: Interleukin 5 deficiency abolishes eosinophilia airways hyperreactivity, and lung damage in a mouse asthma model. J Exp Med 183:195-201, 1996
152. Yoshida T, Ikuta H, Maki K, Takagi M, Sunaga H, Kanazawa H, Kinashi T, Yoshimura K, Miyazaki J, Takaki S, Takatsu K: Defective B-1 cell development and impaired immunity against Angiostronglylus cantonensis in IL5Rα-deficient mice. Immunity 4:483-484, 1996
153. Kopf M, Baumann H, Freer G, Freudenberg M, Lamers M, Kishimoto T, Zinkernagel R, Bluethmann H, Kohler G: Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 368:339-342, 1994
154. von FJU, Vieira P, Lucian LA, McNeil T, Burdach SE, Murray R: Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine. J Exp Med 181:1519-1526, 1995
155. Peschon JJ, Morrissey PJ, Grabstein KH, Ramsdell FJ, Maraskovsky E, Gliniak BC, Park LS, Ziegler SF, Williams DE, Ware CB, Meyer JD, Davison BL: Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice. J Exp Med 180:1955-1960, 1994
156. He Y-W, Malek TR: Interleukin-7 receptor α is essential for the development of γδ+ T cells, but not natural killer cells. J Exp Med 184:289-293, 1996
157. Cacalano G, Lee J, Kikly K, Ryan AM, Pitts-Meek S, Hultgren B, Wood WI, Moore MW: Neutrophil and B cell expansion in mice that lack the murine IL-8 receptor homolog. Science 265:682-684, 1994
158. Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W: Interleukin- 10-deficient mice develop chronic enterocolitis [see comments]. Cell 75:263-274, 1993
159. Magram J, Connaughton SE, Warrier RR, Carvajal DM, Stewart C, Wu C, Ferrante J, Sarmiento U, Faherty DA, Gately MK: IL-12 deficient mice are defective in IFN-γ production and type 1 cytokine responses. Immunity 4:471-481, 1996
160. Zhang J, Bottaro A, Li S, Stewart V, Alt FW: A selective defect in IgG2b switching as a result of targeted mutation of the I gamma 2b promoter and exon. EMBO J 12:3529-3537, 1993
161. Matsuyama T, Kimura T, Kitagawa M, Pfeffer K, Kawakami T, Watanabe N, Kundig TM, Amakawa R, Kishihara K, Wakeham A, Potter J, Furlonger CL, Narendran A, Suzuki H, Ohashi PS, Paige CJ, Tanigushi T, Mak TW: Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development. Cell 75:83-97, 1993
162. Liao XC, Littman DR: Altered T cell receptor signaling and disrupted T
163. Ehlich A, Schaal S, Gu H, Kilamura D, Muller W, Rajewsky K: Immunoglobulin heavy and light chain genes rearrange independently at early stages of B cell development. Cell 72:695-704, 1993
164. Chen J, Troustine M, Kudrahara C, Young F, Koo CC, Xu Y, Loring JF, Alt FW, Huszar D: B cell development in mice that lack one or both immunoglobulin kappa light chain genes. EMBO J 12:821-830, 1993
165. Nussenzweig A, Chen C, Soares VC, Sanchez M, Sokol K, Nussenzweig MC, Li GC: Requirement for Ku80 in growth and immunoglobulin V(D)J recombination. Nature 382:551-555, 1996
166. Zhu C, Bogue MA, Lim D-S, Hasty P, Roth DB: Ku86-deficient mice exhibit severe combined immunodeficiency and defective processing of V(D)J recombination intermediates. Cell 86:379-389, 1996
167. Arbones ML, Ord DC, Ley K, Ratech H, Maynard CC, Otten G, Capon DJ, Tedder TF: Lymphocyte homing and leukocyte rolling and migration are impaired in L-selectin-deficient mice. Immunity 1:247-260, 1994
168. Miyazaki T, Dierich A, Benoist C, Mathis D: Independent modes of natural killing distinguished in mice lacking Lag3. Science 272:405-408, 1996
169. Kitamura D, Kudo A, Schaal S, Muller W, Melchers F, Rajewsky K: A critical role of lambda 5 protein in B cell development. Cell 69:823-831, 1992
170. Viville S, Neefjes J, Lotteau V, Dierich A, Lemeur M, Ploegh H, Benoist C, Mathis D: Mice lacking the MHC class II-associated invariant chain. Cell 72:635-648, 1993
171. Bikoff EK, Huang LY, Episkopou V, van MJ, Germain RN, Robertson EJ: Defective major histocompatibility complex class II assembly, transport, peptide acquisition, and CD4+ T cell selection in mice lacking invariant chain expression. J Exp Med 177:1699-1712, 1993
172. Wong P, Rudensky A: Phenotype and function of CD4+ T cells in mice lacking invariant chain. J Immunol 156:2133-2142, 1996
173. Van Kaer L, Ashton RP, Eichelberger M, Gaczynska M, Nagashima K, Rock KL, Goldberg AL, Doherty PC, Tonegawa S: Altered peptidase and viral-specific T cell response in LMP2 mutant mice. Immunity 1:533-541, 1994
174. Fehling HJ, Swat W, Laplace C, Kuhn R, Rajewsky K, Muller U, van BH: MHC class I expression in mice lacking the proteasome subunit LMP-7. Science 265:1234-1237, 1994
175. Nishizumi H, Taniuchi I, Yamanashi Y, Kitamura D, Ilic D, Mori S, Watanabe T, Yamamoto T: Impaired proliferation of peripheral B cells and indication of autoimmune disease in lyn-deficient mice. Immunity 3:549-560, 1995
176. Hibbs ML, Tarlinton DM, Armes J, Grail D, Hodgson G, Maglitto R, Stacker SA, Dunn AR: Multiple defects in the immune system of Lyn-deficient mice, culminating in autoimmune disease. Cell 83:301-311, 1995
177. Barbosa MDFS, Nguyen QA, Tchernev VT, Ashley JA, Detter JC, Blaydes SM, Brandt ST, Chotai D, Hodgman C, Solari RCE, Lovett M, Kingsmore SF: Identification of the homologous beige and Chediak-Higashi syndrome genes. Nature 382:262-265, 1996
178. Baca ME, Mowat AM, Parrott DMV: Immunological studies of NK cell-deficient beige mice. II. Analysis of T-lymphocyte functions in beige mice. Immunology 66:131-137, 1989
179. Pflumio F, Fonteneau P, Loor F: Impaired antibody response of C57BL/6 beige mutant to a thymus-independent type 2 antigen. Immunol Lett 23:269-274, 1990
180. Grusby MJ, Johnson RS, Papaioannou VE, Glimcher LH: Depletion of CD4+ T cells in major histocompatibility complex class II-deficient mice. Science 253:1417-1420, 1991
181. Cosgrove D, Gray D, Dietrich A, Kaufman J, Lemeur M, Benoist C, Mathis D: Mice lacking MHC class II molecules. Cell 66:1051-1066, 1991
182. Kitamura D, Roes J, Kuhn R, Rajewsky K: A B cell-deficient mouse by targeted disruption of the immunoglobulin μ chain gene. Nature 350:423-426, 1991
183. Kitamura D, Rajewsky K: Targeted disruption of mu chain membrane exon causes loss of heavy-chain allelic exclusion [see comments]. Nature 356:154-156, 1992
184. Sha WC, Liou HC, Tuomanen EI, Baltimore D: Targeted disruption of the p50 subunit of NF-kappa B leads to multifocal defects in immune responses. Cell 80:321-330, 1995
185. Beg AA, Sha WC, Bronson RT, Ghosh S, Baltimore D: Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. Nature 376:167-170, 1995
186. Weih F, Carrasco D, Durham SK, Barton DS, Rizzo CA, Ryseck RP, Lira SA, Bravo R: Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-kappa B/Rel family. Cell 80:331-340, 1995
187. Xanthoudakis S, Viola JPB, Shaw KTY, Luo C, Wallace JD, Bozza PT, Curran T, Rao A: An enhanced immune response in mice lacking the transcription factor NAFT1. Science 272:892-895, 1996
188. Hodge MR, Ranger AM, de la Brousse FC, Hoey T, Grusby MJ, Glimcher LH: Hyperproliferation and dysregulation of IL-4 expression in NF-ATp-deficient mice. Immunity 4:397-405, 1996
189. Corcoran LM, Karvelas M, Nossal GJ, Ye ZS, Jacks T, Baltimore D: Oct-2, although not required for early B-cell development, is critical for later B-cell maturation and for postnatal survival. Genes Dev 7:570-582, 1993
190. Mayadas T, Johnson R, Rayburn H, Hynes R, Wagner D: Leukocyte rolling and extravasation are severely compromised in P selectin-deficient mice. Cell 74:541-554, 1993
191. Nakayama K, Ishida N, Shirane M, Inomata A, Inoue N, Shishido N, Horii I, Loh DY, Nakayama K-I: Mice lacking p27kipl display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 85:707-720, 1996
192. Kiyokawa H, Kineman RD, Manova-Todorova KO, Soards VC, Hoffman ES, Ono M, Khanan D, Hayday AC, Frohman LA, Koff A: Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function p27kip1. Cell 85:721-732, 1996
193. Fero ML, Rivkin M, Tasch M, Porter P, Carow CE, Firpo E, Polyak K, Tsai L-H, Broudy V, Perlmutter RM, Kaushansky K, Roberts JM: A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27kip1-deficient mice. Cell 85:733-744, 1996
194. Gross JA, Appleby MW, Chien S, Nada S, Bartelmez SH, Okada M, Aizawa S, Perlmutter RM: Control of lymphopoiesis by p50csk, a regulatory protein tyrosine kinase. J Exp Med 181:463-473, 1995
195. Imamoto A, Soriano P: Disruption of the csk gene, encoding a negative regulator of src family tyrosine kinases, leads to neural tube defects and embryonic lethality in mice. Cell 73:1117-1124, 1993
196. Nada S, Yagi T, Takeda H, Tokunaga T, Nagakawa H, Ikawa Y, Okada M, Aizawa S: Constitutive activation of src family kinases in mouse embryos that lack Csk. Cell 73:1125-1135, 1993
197. Wen T, Zhang L, Kung SK, Molina TJ, Miller RG, Mak TW: Allo-skin graft rejection, tumor rejection and natural killer activity in mice lacking p561ck. Eur J Immunol 25:3155-3159, 1995
198. Molina TJ, Kishihara K, Siderovski DP, van EW, Narendran A, Timms E, Wakeham A, Paige CJ, Hartmann KU, Veillette A, Davidson D, Mak TW: Profound block in thymocyte development in mice lacking p561ck [see comments]. Nature 357:161-164, 1992
199. Appleby MW, Gross JA, Cooke MP, Levin SD, Qian X, Perlmutter RM: Defective T cell receptor signaling in mice lacking the thymic isoform of p59fyn. Cell 70:751-763, 1992
200. Stein PL, Lee HM, Rich S, Soriano P: p59fyn mutant mice display differential signaling in thymocytes and peripheral T cells. Cell 70:741-750, 1992
201. Urbanek P, Wang ZQ, Fetka I, Wagner EF, Busslinger M: Complete block of early B cell differentiation and altered patterning of the posterior midbrain in mice lacking Pax5/BSAP [see comments]. Cell 79:901-912, 1994
202. Nagasawa T, HIrota S, Tachibana K, Takakura N, Nishikawa S, Kitamura Y, Yoshida N, Kikutani H, Kishimoto T: Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature 382:635-638, 1996
203. Kagi D, Ledermann B, Burki K, Seiler P, Odermatt B, Olsen KJ, Podack ER, Zinkernagel RM, Hengartner H: Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 369:31-37, 1994
204. Walsh CM, Matloubian M, Liu CC, Ueda R, Kurahara CG, Christensen JL, Huang MT, Young JD, Ahmed R, Clark WR: Immune function in mice lacking the perform gene. Proc Natl Acad Sci USA 91:10854-10858, 1994
205. van der Lugt N, Domen J, Verhoeven E, Linders K, van dGH, Allen J, Berns A: Proviral tagging in E mu-myc transgenic mice lacking the Pim-1 protooncogene leads to compensatory activation of Pim-2. EMBO J 14:2536-2544, 1995
206. Leitges M, Schmedt C, Guinamard R, Davoust J, Schaal S, Stabel S, Tarakhovsky A: Immunodeficiency in protein kinase Cβ-deficient mice. Science 273:788-791, 1996
207. Durbin JE, Hackenmiller R, Simon MC, Levy DE: Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease. Cell 84:443-450, 1996
208. Meraz MA, White JM, Sheehan KCF, Bach EA, Rodig SJ, Dighe AS, Kaplan D, Campbell D, Carver-Moore K, DuBois RN, Clark R, Aguet M, Schreiber RD: Targeted disruption of the Stat1 gene in mice reveals unexpected psycologic specificity in the JAK-STAT signaling pathway. Cell 84:431-442, 1996
209. Thierfelder WE, van Deursen J, Yamamoto K, Tripp R, Sarawar S, Carson R, Sangster M, Vignalli D, Doherty P, Grosveld G, Ihle J: Requirement for Stat4 in interleukin-12 mediated responses of natural killer and T cells. Nature 382:171-174, 1996
210. Kaplan M, Sun Y-L, Hoey T, Grusby M: Impaired IL-12 responses and enhanced development of TH2 cells in stat4-deficient mice. Nature 382:174-177, 1996
211. Takeda K, Tanaka T, Shi W, Matsumoto M, Minami M, Kashiwamura S, Nakanishi K, Yoshida N, Kishimoto T, Akira S: Essential role of Stat6 in IL-4 signalling. Nature 380:627-630, 1996
212. Shimoda K, van DJ, Sangster MY, Sarawar SR, Carson RT, Tripp RA, Chu C, Quelle FW, Nosaka T, Vignali DA, Doherty PC, Grosveld G, Paul WE, Ihle JN: Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene. Nature 380:630-633, 1996
213. Bozic CR, Lu B, Hopken UE, Gerard C, Gerard NP: Neurogenic amplification of immune complex inflamation. Science 273: 1722-1725, 1996
214. Jung S, Rajewsky K, Radbruch A: Shutdown of class switch recombination by deletion of a switch region control element. Science 259:984-987, 1993
215. Turner M, Mee PJ, Costello PS, Williams O, Price AA, Duddy LP, Furlong MT, Geahlen RL, Tybulewicz VL: Perinatal lethality and blocked B-cell development in mice lacking the tyrosine kinase Syk. Nature 378:298-302, 1995
216. Cheng AM, Rowley B, Pao W, Hayday A, Bohlen JB, Pawson T: Syk tyrosine kinase required for mouse viability and B-cell development. Nature 378:303-306, 1995
217. Verbeek S, Izon D, HOfhuis F, Robanus ME, te RH, van dWM, Oosterwegel M, Wilson A, MacDonald HR, Clevers H: An HMG-box-containing T-cell factor required for thymocyte differentiation. Nature 374:70-74, 1995
218. Philpott KL, Viney JL, Kay G, Rastan S, Gardiner EM, Chae S, Hayday AC, Owen MJ: Lympoid development in mice congenitally lacking T cell receptor alpha beta-expressing cells. Science 256:1488-1452, 1992
219. Wen L, Roberts SJ, Viney JL, Wong FS, Mallick C, Findly RC, Peng Q, Craft JE, Owen MJ, Hayday AC: Immunoglobulin synthesis and generalized autoimmunity in mice congenitally deficient in αβ (+) T cells. Nature 369:654-658, 1994
220. Viney JL, Dianada L, Roberts SJ, Wen L, Mallick CA, Hayday AC, Owen MJ: Lymphocyte proliferation in mice congenitally deficient in T-cell receptor alpha beta+ cells. Proc. Natl Acad Sci USA 91:11948-11952, 1994
221. Mombaerts P, Mizoguchi E, Grusby MJ, Glimcher LH, Bhan AK, Tonegawa S: Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice [see comments]. Cell 75:274-282, 1993
222. Mombaerts P, Mizoguchi E, Ljunggren HG, Iacomini J, Ishikawa H, Wang L, Grusby MJ, Glimcher LH, Winn HJ, Bhan AK, Tonegawa S: Peripheral lympoid development and function in TCR mutant mice. Int Immunol 6:1061-1070, 1994
223. Mombaerts P, Clarke AR, Rudnicki MA, Iacomini J, Itohara S, Lafaille JJ, Want L, Ichikawa Y, Jaenisch R, Hooper ML, Tonegawa S: Mutations in T-cell antigen receptor genes alpha and beta block thymocyte development stages. Nature 360:225-231, 1992 (published Erratum appears in Nature 360:491, 1992)
224. Itohara S, Mombaerts P, Lafille J, Iacomini J, Nelson A, Clarke AR, Hooper ML, Farr A, Tonegawa S: T cell receptor delta gene mutant mice: independent generation of alpha beta T cells and programmed rearrangements of gamma delta TCR genes. Cell 72:337-348, 1993
225. Gilfillan S, Dierich A, Lemeur M, Benoist C, Mathis D: Mice lacking TdT: mature animals with an immature lymphocyte repertoire. Science 261:1175-1178, 1993 (published Erratum appears in Science 262:1957, 1993)
226. Komori DT, Okada A, Stewart V, Alt FW: Lack of N regions in antigen receptor variable region genes of TdT-deficient lymphocytes. Science 261:1171-1175, 1993
227. Gilfillan S, Bachmann M, Trembleau S, Adorini L, Kalinke U, Zinkernagel R, Benoist C, Mathis D: Efficient immune responses in mice lacking N-region diversity. Eur J Immunol 25:3115-3122, 1995
228. Shull MM, Ormsby I, Kier AB, Pawlowski S, Diebold RJ, Yin M, Allen R, Sidman C, Proetzel G, Calvin D, Annunziata N, Doetschman T: Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 359:693-699, 1992
229. De Togni P, Goellner J, Ruddle NH, Streeter PR, Fick A, Mariathasan S, Smith SC, Carlson R, Shornick LP, Strauss-Schoenberger J, Russell JH, Karr R, Chaplin DD: Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin [see comments]. Science 264:703-707, 1994
230. Banks TA, Rouse BT, Kerley MK, Blair PJ, Godfrey VL, Kuklin NA, Bouley DM, Thomas J, Kanangat S, Mucenski ML: Lymphotoxin-alpha-deficient mice. Effects on secondary lymphoid organ development and humoral immune responsiveness. J Immunol 155:1685-1693, 1995
231. Matsumoto M, Mariathasan S, Nahm MH, Baranyay F, Peschon JJ, Chaplin DD: Role of lymphotoxin and the type I TNF receptor in the formation of germinal centers. Science 271:1289-1291, 1996
232. Rothe J, Lesslauer W, Lotscher H, Lang Y, Koebel P, Kontgen F, Althage A, Zinkernagel R, Steinmetz M, Bluethmann H: Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature 364:798-802, 1993
233. Pfeffer K, Matsuyama T, Kundig TM, Wakeham A, Kishihara K, Shahinian A, Wiegmann K, Ohashi PS, Kronke M, Mak TW: Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 73:457-467, 1993
234. Matsumoto M, Mariathasan S, Nahm MH, Baranyay F, Peschon JJ, Chaplin DD: Role of lymphotoxin and the type I TNF receptor in the formation of germinal centers. Science 271:1289-1294, 1996
235. Vieira L, Goldschmidt M, Nashleanas M, Pfeffer K, Mak T, Scott P: Mice lacking the TNF receptor p55 fail to resolve lesions caused by infection with Leishmania major, but control parasite replication. J Immunol 157:827-835, 1996
236. Tarakhovsky A, Turner M, Schaal S, Mee PJ, Duddy LP, Rajewsky K, Tybulewicz VL: Defective antigen receptor-mediated proliferation of B and T cells in the absence of Vav. Nature 374:467-470, 1995
237. Zhang R, Alt FW, Davidson L, Orkin SH, Swat W: Defective signalling through the T- and B-cell antigen receptors in lymphoid cells lacking the vav proto-oncogene. Nature 374:470-473, 1995
238. Nehls M, Kyewski B, Messerle M, Waldschutz R, Schuddekpf K, Smith AJ, Boehm T: Two genetically separable steps in the differentiation of thymic epithelium. Science 272:886-889, 1996